Frank W. Hobbs

5.5k total citations · 2 hit papers
18 papers, 4.2k citations indexed

About

Frank W. Hobbs is a scholar working on Molecular Biology, Organic Chemistry and Biochemistry. According to data from OpenAlex, Frank W. Hobbs has authored 18 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 6 papers in Organic Chemistry and 3 papers in Biochemistry. Recurrent topics in Frank W. Hobbs's work include DNA and Nucleic Acid Chemistry (5 papers), Advanced biosensing and bioanalysis techniques (4 papers) and Amino Acid Enzymes and Metabolism (2 papers). Frank W. Hobbs is often cited by papers focused on DNA and Nucleic Acid Chemistry (5 papers), Advanced biosensing and bioanalysis techniques (4 papers) and Amino Acid Enzymes and Metabolism (2 papers). Frank W. Hobbs collaborates with scholars based in United States. Frank W. Hobbs's co-authors include Robert A. Copeland, Kurumi Y. Horiuchi, James M. Trzăskos, Peggy Scherle, Margaret Favata, Ronald L. Magolda, William J. Pitts, Drew E. Van Dyk, Richard A. Earl and Elizabeth J. Manos and has published in prestigious journals such as Science, Journal of the American Chemical Society and Nucleic Acids Research.

In The Last Decade

Frank W. Hobbs

18 papers receiving 4.1k citations

Hit Papers

Identification of a Novel Inhibitor of Mitogen-activated ... 1987 2026 2000 2013 1998 1987 500 1000 1.5k 2.0k 2.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Frank W. Hobbs United States 14 2.8k 553 506 381 378 18 4.2k
ISAMI TAKAHASHI Japan 19 3.2k 1.1× 605 1.1× 442 0.9× 471 1.2× 711 1.9× 29 4.6k
William F. Matter United States 14 3.1k 1.1× 689 1.2× 749 1.5× 403 1.1× 222 0.6× 19 4.5k
Kurumi Y. Horiuchi United States 22 2.5k 0.9× 602 1.1× 457 0.9× 435 1.1× 161 0.4× 33 3.8k
M. Sikorska Canada 22 2.6k 0.9× 559 1.0× 359 0.7× 328 0.9× 131 0.3× 44 3.6k
Ronald E. Diehl United States 25 2.8k 1.0× 651 1.2× 399 0.8× 669 1.8× 193 0.5× 33 4.2k
Margarita García‐Calvo United States 22 4.0k 1.5× 576 1.0× 798 1.6× 636 1.7× 296 0.8× 38 5.1k
Drew E. Van Dyk United States 10 2.4k 0.9× 527 1.0× 443 0.9× 361 0.9× 111 0.3× 11 3.5k
Randall L. Kincaid United States 33 3.0k 1.1× 683 1.2× 815 1.6× 559 1.5× 151 0.4× 68 4.1k
Hilary McLauchlan United Kingdom 13 3.2k 1.2× 775 1.4× 431 0.9× 537 1.4× 303 0.8× 16 4.6k
Masao Iwamori Japan 35 2.9k 1.0× 294 0.5× 944 1.9× 317 0.8× 513 1.4× 212 4.4k

Countries citing papers authored by Frank W. Hobbs

Since Specialization
Citations

This map shows the geographic impact of Frank W. Hobbs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank W. Hobbs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank W. Hobbs more than expected).

Fields of papers citing papers by Frank W. Hobbs

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frank W. Hobbs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank W. Hobbs. The network helps show where Frank W. Hobbs may publish in the future.

Co-authorship network of co-authors of Frank W. Hobbs

This figure shows the co-authorship network connecting the top 25 collaborators of Frank W. Hobbs. A scholar is included among the top collaborators of Frank W. Hobbs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frank W. Hobbs. Frank W. Hobbs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Wityak, John, Frank W. Hobbs, Daniel S. Gardner, et al.. (2004). Beyond U0126. Dianion chemistry leading to the rapid synthesis of a series of potent MEK inhibitors. Bioorganic & Medicinal Chemistry Letters. 14(6). 1483–1486. 24 indexed citations
2.
Haque, Tasir S., Seifu Tadesse, Jovita Marcinkeviciene, et al.. (2002). Parallel Synthesis of Potent, Pyrazole-Based Inhibitors of Helicobacter pylori Dihydroorotate Dehydrogenase. Journal of Medicinal Chemistry. 45(21). 4669–4678. 49 indexed citations
3.
Hobbs, Frank W., et al.. (2001). Oxazolidinones Mechanism of Action: Inhibition of the First Peptide Bond Formation. Journal of Biological Chemistry. 276(40). 37199–37205. 33 indexed citations
4.
Copeland, Robert A., Jovita Marcinkeviciene, Tasir S. Haque, et al.. (2000). Helicobacter pylori-selective Antibacterials Based on Inhibition of Pyrimidine Biosynthesis. Journal of Biological Chemistry. 275(43). 33373–33378. 56 indexed citations
5.
Cocuzza, Anthony J., et al.. (1999). 4-Aryl-2-anilinopyrimidines as corticotropin-releasing hormone (CRH) antagonists. Bioorganic & Medicinal Chemistry Letters. 9(7). 1057–1062. 13 indexed citations
6.
Favata, Margaret, Kurumi Y. Horiuchi, Elizabeth J. Manos, et al.. (1998). Identification of a Novel Inhibitor of Mitogen-activated Protein Kinase Kinase. Journal of Biological Chemistry. 273(29). 18623–18632. 2750 indexed citations breakdown →
7.
Sands, Howard, et al.. (1995). Biodistribution and metabolism of internally 3H-labeled oligonucleotides. II. 3',5'-blocked oligonucleotides.. Molecular Pharmacology. 47(3). 636–646. 81 indexed citations
8.
Sands, Howard, et al.. (1994). Biodistribution and metabolism of internally 3H-labeled oligonucleotides. I. Comparison of a phosphodiester and a phosphorothioate.. Molecular Pharmacology. 45(5). 932–943. 232 indexed citations
9.
Hobbs, Frank W., et al.. (1993). 7,8-Dihydro-8-oxoadenine as a replacement for cytosine in the third strand of triple helixes. Triplex formation without hypochromicity. Biochemistry. 32(13). 3249–3254. 53 indexed citations
10.
Hobbs, Frank W., et al.. (1993). Denaturing HPLC purification of tritylated oligonucleotides using tetraethylammonium hydroxide.. PubMed. 14(4). 584–91. 2 indexed citations
11.
Livak, Kenneth J., Frank W. Hobbs, & Robert J. Zagursky. (1992). Detection of single base differences using biotinylated nucleotides with very long linker arms. Nucleic Acids Research. 20(18). 4831–4837. 11 indexed citations
12.
Snider, Barry B., et al.. (1989). Cytotoxicity of synthetic racemic ptilocaulin: A novel cyclic guanidine. Investigational New Drugs. 7(2-3). 147–154. 9 indexed citations
13.
Hobbs, Frank W.. (1989). Palladium-catalyzed synthesis of alkynylamino nucleosides. A universal linker for nucleic acids. The Journal of Organic Chemistry. 54(14). 3420–3422. 151 indexed citations
14.
Meek, James L., et al.. (1988). Synthesis of inositol phosphates. Journal of the American Chemical Society. 110(7). 2317–2318. 45 indexed citations
15.
Druliner, J. D., et al.. (1988). Concerning enhanced reactivities of .alpha.-keto hydroperoxides. The Journal of Organic Chemistry. 53(3). 700–702. 6 indexed citations
16.
Trainor, George L., Rudy J. Dam, Frank W. Hobbs, et al.. (1987). A System for Rapid DNA Sequencing with Fluorescent Chain-Terminating Dideoxynucleotides. Science. 238(4825). 336–341. 601 indexed citations breakdown →
17.
Nugent, William A. & Frank W. Hobbs. (1986). Improved route to 3-vinyl substituted cyclopentanones. Synthesis of (.+-.)-mitsugashiwalactone. The Journal of Organic Chemistry. 51(17). 3376–3378. 22 indexed citations
18.
Nugent, William A. & Frank W. Hobbs. (1983). A regiospecific, convergent route to 2,3-disubstituted cyclopentanones. The Journal of Organic Chemistry. 48(26). 5364–5366. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026